Nuclear Medicine and Biology
Volume 33, Issue 6 , Pages 735-741 , August 2006

Comparison of the uptake of [123/125I]-2-iodo-d-tyrosine and [123/125I]-2-iodo-l-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo

  • Matthias Bauwens

      Affiliations

    • Radiopharmaceutical Chemistry, BEFY, Vrije Universiteit Brussel, 1090 Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 2 477 48 60; fax: +32 2 477 48 55.
    • ,
  • Tony Lahoutte

      Affiliations

    • In Vivo Cellular Imaging Center (ICMIC), Vrije Universiteit Brussel, 1090 Brussels, Belgium
    • ,
  • Ken Kersemans

      Affiliations

    • Radiopharmaceutical Chemistry, BEFY, Vrije Universiteit Brussel, 1090 Brussels, Belgium
    • ,
  • Carol Gallez

      Affiliations

    • In Vivo Cellular Imaging Center (ICMIC), Vrije Universiteit Brussel, 1090 Brussels, Belgium
    • ,
  • Axel Bossuyt

      Affiliations

    • In Vivo Cellular Imaging Center (ICMIC), Vrije Universiteit Brussel, 1090 Brussels, Belgium
    • ,
  • John Mertens

      Affiliations

    • Radiopharmaceutical Chemistry, BEFY, Vrije Universiteit Brussel, 1090 Brussels, Belgium

Received 20 March 2006 ,Revised 3 May 2006 ,Accepted 8 May 2006.

References 

  1. Tamemasa O, Goto R, Suzuki T. Preferential incorporation of some 14C-labeled d-amino acids into tumour-bearing animals. Gann. 1978;69:517–523
  2. Goto R, Suzuki T, Tamemasa O. Charateristics of d-leucine uptake by Mouse Ehrlich cells ascites tumour cells. J Biochem. 1979;86:363–369
  3. Takeda A, Goto R, Tamemasa O, Chaney JE, Digenis GA. Biological evaluation of radiolabelled d-methionine as a parent compound in potential nuclear imaging. Radioisotopes. 1984;33:213–217
  4. Ohkame H, Masuda H, Ishii Y, Kanai Y. Expression of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain in liver tumour lesions of rat models. Journal of Surgical Oncology. 2001;78:265–272
  5. Meier C, Ristic Z, Klauser S, Verrey F. Activation of system l heterodimeric amino acid exchangers by intracellular substrates. EMBO J. 2002;21:580–589
  6. Lahoutte T, Caveliers V, Camargo SM, Franca R, Ramadan T, Veljkovic E, et al. SPECT and PET amino acid tracer influx via system l (h4F2hc-hLAT1) and its transstimulation. J Nucl Med. 2004;45:1591–1596
  7. Yanagida O, Kanai Y. Human l-type amino acid transport system 1 (LAT1): characterisation of function and expression in tumour cell lines. Biochim Biophys Acta. 2001;1514:291–302
  8. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y. Identification and functional characterisation of a Na+-independent neutral l-amino acid transporter with broad substrate selectivity. J Biol Chem. 1999;274:19745–19751
  9. Babu E, Kanai Y, Chairoungdua A, Kim do K, Iribe Y, Tangtrongsup S, et al. Identification of a novel system l amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003;31(278):43838–43845
  10. Bodoy S, Martin L, Zorzano A, Palacin M, Estevez R, Bertran J. Identification of LAT4, a novel amino acid transporter with system l activity, J Biol Chem 2005:25;280(12):12002–11.
  11. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterisation of a transporters for large neutral amino acids activated by heavy chain 4F2 antigen (CD98). J Biol Chem. 1998;273:23629–23632
  12. Campbell WA, Thompson NL. Overexpression of LAT1/CD98 light chain is sufficient to increase system l-amino acid transport activity in mouse hepatocytes but not fibroblasts. J Biol Chem. 2001;276:16877–16884
  13. Kim do K, Kanai Y, Choi HW, et al. Characterization of the l amino acid transporter in T24 human bladder carcinoma cells. Biochem Biophys Acta. 2002;1565(1):112
  14. Kupczyk-Subotkowska L, Tamura K, Pal D, Sakaeda T, Siahaan TJ, Stella VJ, et al. Derivatives of melphalan designed to enhance drug accumulation in cancer cells. J Drug Target. 1997;4(6):359–370
  15. Rajan DP, Kekuda R, Huang W, Devoe LD, Leibach FH, Prasad PD, et al. Cloning and functional characterisation of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine. Biochim Biophys Acta. 2000;1463:6–14
  16. Meyer GJ, Schober O, Hundeshagen H. Uptake of 11C-l- and d-methionine in brain tumours. Eur J Nucl Med. 1985;10(7–8):373–376
  17. Bergstrom M, Muhr C, Ericson K, et al. The normal pituitary examined with positron emission tomography and (methyl-11C)-l-methionine and (methyl-11C)-d-methionine. Neuroradiology. 1987;29:221–225
  18. Kersemans V, Cornelissen B, Kersemans K, Bauwens M, Dierckx RA, De Spiegeleer B, et al. (123/125)I-labelled 2-iodo-l-phenylalanine and 2-iodo-d-phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Eur J Nucl Med Mol Imaging. 2006;
  19. Kersemans V. Synthesis, in vitro/in vivo evaluation of 2-iodo-l-phenylalanine and its d-isomer as tumour tracers in oncology. PhD thesis presented at Ugent, 2005
  20. Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. J Nucl Med. 2003;44:1489–1494
  21. Mertens J, Kersemans V, Bauwens M, et al. Synthesis, radiosynthesis and in vitro characterisation of [125I]-2-iodo-l-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumour tracer for SPECT. Nucl Med Biol. 2004;31:739–746
  22. Kersemans V, Cornelissen B, Kersemans K, Bauwens M, Achten E, Dierckx RA, et al. In vivo characterization of 123I/125I-2-iodo-l-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumour tracer for SPECT. J Nucl Med. 2005;46(3):532–539
  23. Mertens J, Kersemans V, Bauwens M, et al. Radioactive labelled d-amino acid analogues, a new perspective for tumour therapy and diagnosis: an in vitro evaluation model. Eur J Nucl Med. 2003;30(Suppl 2):530
  24. Kersemans V, Cornelissen B, Bacher K, Kersemans K, Thierens H, Dierckx R, et al. In vivo evaluation and dosimetry of 123I-2-iodo-d-phenylalanine, a new potential tumour-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. J Nucl Med. 2005;46:2104–2111
  25. Tsukada H, Sato K, Fukumoto D, Nishiyama S, Harada N, Kakiuchi T. Evaluation of d-Isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with l- and d-11C-methionine. J Nucl Med. 2006;47(4):679–688
  26. Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-l-tyrosine in vitro and in vivo. J Nucl Med. 1999;40(8):1367–1373
  27. Langen KJ, Hamacher K, Pauleit D, Floeth FW, Stoffels G, Bauer D, et al. Evaluation of new 18F-labeled amino acids for brain PET. Anat Embryol (Berl). 2005;210(5–6):455–461
  28. Broer A, Klingel K, Kowalczuk S, Rasko JE, Cavanaugh J, Broer S. Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder. J Biol Chem. 2004;279(23):24467–24476
  29. Langen KJ, Hamacher K, Bauer D, Broer S, Pauleit D, Herzog H, et al. Preferred stereoselective transport of the d-isomer of cis-4-[18F]fluoro-proline at the blood–brain barrier. J Cereb Blood Flow Metab. 2005;25(5):607–616
  30. Biersack HJ, Coenen HH, Stocklin G, et al. Imaging of brain tumors with l-3-123I-iodo-alpha-methyltyrosine and SPECT. J Nucl Med. 1989;30:110
  31. Mertens J, Vekeman M, Joos C, et al. Uptake study of l-2-125I-tyrosine, a new tracer in human colon carcinoma WiDr cells. Eur J Nucl Med. 2000;27:1063
  32. Lahoutte T, Caveliers V, Dierickx L, Vekeman M, Everaert H, Mertens J, et al. In vitro characterisation of the influx of 3-[125I]-iodo-l-α-methyl-tyrosine and 2-[125I]-iodo-l-tyrosine into U266 human myeloma cells: evidence for system T transport. Nucl Med Biol. 2001;28:129–134
  33. Kersemans V, Cornelissen B, Kersemans K, Dierckx R, Mertens J, Slegers G. Comparative distribution study of the new tumour tracer 123I-2-iodo-phenylalanine with 123I-2-iodo-tyrosine. Nucl Med Biol. 2006;33(1):111–117

☆ The first author is currently working on his PhD degree.

PII: S0969-8051(06)00092-8

doi: 10.1016/j.nucmedbio.2006.05.004

Nuclear Medicine and Biology
Volume 33, Issue 6 , Pages 735-741 , August 2006

Article Tools

* Image Usage & Resolution